TY - JOUR AU - Styczynski, Jan PY - 2013 TI - Relapsed acute myeloblastic leukemia: first pediatric randomized study JF - Translational Pediatrics; Vol 2, No 2 (April 03, 2013): Translational Pediatrics Y2 - 2013 KW - N2 - The current cure rate achieves 80% of long-term survival in childhood acute lymphoblastic leukemia (ALL) and only 50-60% in acute myeloblastic leukemia (AML) (1). However, in patients who relapse following treatment of AML, the odds are not as far in their favor, and the probability of overall survival is 16-34% (2,3). UR - https://tp.amegroups.org/article/view/1833